Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Kinross Gold | 5.71% | $3.56M | $41.74B | 189.86% | 81 Outperform | |
| Novartis AG | 4.48% | $2.79M | CHF242.43B | 31.88% | 80 Outperform | |
| Rio Tinto Limited | 4.25% | $2.65M | AU$238.88B | 50.38% | 78 Outperform | |
| Nutrien | 4.08% | $2.54M | C$46.56B | 33.99% | 75 Outperform | |
| BAE Systems | 4.07% | $2.54M | £61.53B | 72.63% | 61 Neutral | |
| Sumitomo Mitsui Financial Group | 3.43% | $2.14M | ¥22.61T | 67.28% | 77 Outperform | |
| Mitsubishi Electric | 3.21% | $2.00M | ¥11.82T | 104.84% | 72 Outperform | |
| AstraZeneca | 3.11% | $1.94M | £240.98B | 32.79% | 80 Outperform | |
| Rexel SA | 3.08% | $1.92M | €10.60B | 38.24% | 65 Neutral | |
| Nordea Bank Abp | 2.99% | $1.86M | kr611.49B | 54.80% | ― |